December 9
Urodynamix To Evaluate Strategic Alternatives
November 30
Urodynamix Reports Fiscal 2009 Third Quarter Results
October 8
Urodynamix Announces Pilot Program with Cardinal Health
September 28
Urodynamix Closes $1.5 Million Placement
September 11
Urodynamix Announces $1.5 Million Private Placement
August 27
Urodynamix Reports Fiscal 2009 Second Quarter Results
June 1
Urodynamix Reports Fiscal 2009 First Quarter Results
May 13
Urodynamix Announces Grant of Stock Options
April 28
Urodynamix receives financial contribution from NRC-IRAP to support development of NIRS technology to improve the MIT of BPH
April 7
Urodynamix Announces Completion of Commercial Shipment of uroNIRS 2000 to Medical Measurement Systems B.V.
April 2
Urodynamix Expands Asian Distribution of uroNIRS 2000
February 26
Urodynamix Receives CE Mark MMS to launch uroNIRS 2000™ Bladder Monitor System at the Annual EAU in Stockholm Sweden
January 5
Urodynamix Receives FDA 510(k) Clearance for uroNIRS 2000™ Bladder Monitor System
November 24
Urodynamix Presents First Data on Use of NIRS and Transurethral Microwave Therapy at the 26th World Congress of Endourology Conference
November 13
Urodynamix and Pfizer Inc. Launch Promotional Program in Boston
November 6
Urodynamix Technologies Ltd. Closes $2.5 Million Private Placement
November 3
Urodynamix Appoints Chief Financial Officer
October 22
Urodynamix and Laborie Medical Expand Distribution Rights
October 21
Urodynamix and Medical Measurement Systems Announce Worldwide Agreement to Expand Distribution for Bladder Product
October 15
BC Advantage Funds Increases Stake in Urodynamix Technologies Ltd.
October 9
Urodynamix Announces Publication of Two Articles in Canadian Journal of Urology
October 6
Urodynamix and Timm Medical Sign Development and Distribution Agreement
September 23
Urodynamix and Pfizer Inc. Collaborate on Urologist Program
September 17
Urodynamix Submits 510(k) Filing to FDA for Second Generation Bladder Monitor
September 2
Laborie Receives CE Mark and Canadian Medical Device Licence for Tetra Bladder Monitor System
August 25
Urodynamix Awarded NRC-IRAP Support for New Prostate Cancer Detection Technology
June 10
Urodynamix Appoints Vice President of Business Development
June 4
Urodynamix Launches Tetra-NIRS Marketing Trials
May 20
Urodynamix and Laborie Launch Tetra(TM) Bladder Monitor System
Urodynamix Announces First Commercial Product Shipment
March 31
Urodynamix Technologies Receives ISO 13485 Certification
March 25
Urodynamix Announces Second Collaboration for Development of NIRS Prostate Treatment Device
March 11
March 10
Laborie Medical Technologies Receives FDA 510(k) Clearance for Tetra™ Bladder Monitor System
March 3
Urodynamix Signs Collaborative Agreement for NIRS Prostate Treatment Device
Urodynamix Develops Next Generation NIRS Prostate Monitoring System
February 6
Urodynamix NIRS IAP Data Presented at Society of Critical Care Medicine Annual Meeting
January 4
2007
December 19
Urodynamix Technologies Announces Positive Data from LUTS Pivotal Trial
December 17
Laborie Medical Technologies Submits 510(k) Application to FDA for Tetra(TM) Bladder Monitor System
Urodynamix Announces New Device to Help Diagnose Prostate Cancer
October 4
Urodynamix Appoints David Goodkin, MD to Board of Directors
September 18
September 13
Urodynamix Commences Enrollment in Third IAP Clinical Trial
August 31
Urodynamix and Laborie to Exhibit at SIU 2007
August 20
Urodynamix and Laborie to Exhibit at ICS 2007
August 14
Urodynamix Warrant Exercise Raises $900,000
July 26
Funds Managed by Lions Capital Acquire Additional Interest in Urodynamix Technologies
July 25
Urodynamix Raises $1.9 Million from Exercise of Warrants
June 8
June 7
Urodynamix Files Patent Applications
June 6
Urodynamix Reports 2007 Annual Meeting Results
May 23
Urodynamix Cancels Proposed Share Consolidation
May 18
Urodynamix and Laborie Medical Technologies to Unveil URO-NIRS Bladder Monitor at the 2007 American Urological Association Annual Meeting
May 17
Urodynamix and Laborie Medical Technologies Announce Worldwide Distribution Agreement
May 16
Urodynamix Announces NIRS Data to be Presented at 2007 American Urological Association Annual Meeting
May 8
Urodynamix Data to be Presented at Leading Trauma Conference
May 4
Urodynamix Announces Annual and Special Shareholder Meeting Agenda
April 12
Urodynamix Expands NIRS Intra-Abdominal Pressure Study
March 8
Urodynamix Reports Positive Results from Second Female UI Study
Urodynamix Announces Positive Results from NIRS Prostate Study 2
February 21
Urodynamix Discovers NIRS Application for Diagnosis of Erectile Dysfunction
February 20
Urodynamix Forms Medical Advisory Board
February 19
Urodynamix Appoints Corporate Secretary
January 17
Urodynamix Discovers New NIRS Application
